ALK-Abello was founded as Allergologisk Laboratorium Kobenhavn, which became part of the public traded Chr. Hansen Group. ALK-Abello’s is focused on vaccination for allergies and the products include emergency allergy treatment, allergy diagnosis and allergy prevention. The company’s main marketed products are ALK 7, Alutard® SQ, Aquagen SQ, EpiPen®/EpiPen® Jr, Pangramin® Depot UM, Pangramin® SLIT, Pharmalgen, Profylac, SLITone™, Soluprick® SQ/ALK-prick/Pangramin®-Prick UM and TRUETest.